Earnings Per Share

6 Months Ended

Jun. 30, 2023

Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Numerator:
Net income (loss) attributable to Surgery Partners, Inc.	$	18.9	$	(18.4)	$	(6.0)	$	(6.2)

Denominator:
Weighted average shares outstanding- basic	125,718		88,900		125,463		88,450
Weighted average shares outstanding- diluted (1)	127,370		88,900		125,463		88,450

Income (loss) per share:
Basic	$	0.15	$	(0.21)	$	(0.05)	$	(0.07)
Diluted (1)	$	0.15	$	(0.21)	$	(0.05)	$	(0.07)

Dilutive securities outstanding not included in the computation of income (loss) per share as their effect is antidilutive:
Stock options	—		1,559		1,407		1,599
Restricted shares	—		628		147		644

(1)The impact of potentially dilutive securities for the three months ended June 30, 2022 and the six months ended June 30, 2023 and 2022, was not considered because the effect would be anti-dilutive.